Novoprotein Scientific Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Novoprotein Scientific has a total shareholder equity of CN¥2.1B and total debt of CN¥18.1M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥2.2B and CN¥108.8M respectively.
Wichtige Informationen
0.8%
Verhältnis von Schulden zu Eigenkapital
CN¥18.11m
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | CN¥668.95m |
| Eigenkapital | CN¥2.13b |
| Gesamtverbindlichkeiten | CN¥108.78m |
| Gesamtvermögen | CN¥2.24b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 688137's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥54.6M).
Langfristige Verbindlichkeiten: 688137's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥54.2M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 688137 has more cash than its total debt.
Schulden abbauen: 688137 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Schuldendeckung: 688137's debt is well covered by operating cash flow (205.7%).
Zinsdeckung: Insufficient data to determine if 688137's interest payments on its debt are well covered by EBIT.